Literature DB >> 25077670

Oral immunotherapy for food allergy: mechanisms and role in management.

A Nowak-Węgrzyn1, S Albin.   

Abstract

With the emergence of food allergy as an important public health problem, it has become clear that there is an unmet need in regard to treatment. In particular, IgE-mediated food allergy that is associated with risk of fatal anaphylaxis has been the subject of multiple studies in the past decade. The growing body of evidence derived from multiple centres and various study designs indicates that for IgE-mediated food allergy, immunomodulation through food immunotherapy is possible; however, the extent of protection afforded by such treatment is highly variable. At this time, the capacity for food immunotherapy to restore permanent tolerance to food has not been demonstrated conclusively. This review will discuss these topics as they apply to the most important studies of food oral immunotherapy.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25077670     DOI: 10.1111/cea.12382

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  9 in total

1.  Effect of chemical modifications on allergenic potency of peanut proteins.

Authors:  Ramon Bencharitiwong; Hanneke P M van der Kleij; Stef J Koppelman; Anna Nowak-Węgrzyn
Journal:  Allergy Asthma Proc       Date:  2015 May-Jun       Impact factor: 2.587

Review 2.  Food Allergy: Our Evolving Understanding of Its Pathogenesis, Prevention, and Treatment.

Authors:  Onyinye I Iweala; A Wesley Burks
Journal:  Curr Allergy Asthma Rep       Date:  2016-05       Impact factor: 4.806

3.  Analysis of cytokine production by peanut-reactive T cells identifies residual Th2 effectors in highly allergic children who received peanut oral immunotherapy.

Authors:  J A Wisniewski; S P Commins; R Agrawal; K E Hulse; M D Yu; J Cronin; P W Heymann; A Pomes; T A Platts-Mills; L Workman; J A Woodfolk
Journal:  Clin Exp Allergy       Date:  2015-07       Impact factor: 5.018

4.  Improvement of Therapeutic Efficacy of Oral Immunotherapy in Combination with Regulatory T Cell-Inducer Kakkonto in a Murine Food Allergy Model.

Authors:  Yuka Nagata; Takeshi Yamamoto; Michie Hayashi; Shusaku Hayashi; Makoto Kadowaki
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

5.  Oral Immunotherapy With Partially Hydrolyzed Wheat-Based Cereals: A Pilot Study.

Authors:  Roger Lauener; Philippe A Eigenmann; Jacqueline Wassenberg; Andreas Jung; Sandra Denery-Papini; Sigrid Sjölander; Sophie Pecquet; Rodolphe Fritsché; Adrian Zuercher; Antoine Wermeille; Massimo Fontanesi; Annick Mercenier; Yvonne M Vissers; Sophie Nutten
Journal:  Clin Med Insights Pediatr       Date:  2017-09-08

6.  Single-dose AAV vector gene immunotherapy to treat food allergy.

Authors:  Miguel Gonzalez-Visiedo; Xin Li; Maite Munoz-Melero; Michael D Kulis; Henry Daniell; David M Markusic
Journal:  Mol Ther Methods Clin Dev       Date:  2022-07-16       Impact factor: 5.849

Review 7.  Biomarkers in oral immunotherapy.

Authors:  Haitao Zhu; Kaifa Tang; Guoqiang Chen; Zhongwei Liu
Journal:  J Zhejiang Univ Sci B       Date:  2022 Sept 15       Impact factor: 5.552

8.  Removal of peanut allergen Ara h 1 from common hospital surfaces, toys and books using standard cleaning methods.

Authors:  Wade Ta Watson; AnnMarie Woodrow; Andrew W Stadnyk
Journal:  Allergy Asthma Clin Immunol       Date:  2015-01-23       Impact factor: 3.406

9.  Dietary Supplementation with Nondigestible Oligosaccharides Reduces Allergic Symptoms and Supports Low Dose Oral Immunotherapy in a Peanut Allergy Mouse Model.

Authors:  Laura Wagenaar; Marianne Bol-Schoenmakers; Giulio Giustarini; Marlotte M Vonk; Betty C A M van Esch; Leon M J Knippels; Johan Garssen; Joost J Smit; Raymond H H Pieters
Journal:  Mol Nutr Food Res       Date:  2018-08-31       Impact factor: 5.914

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.